EMR vs VIR · P/E 34, rev $4.86B vs rev $238.9M
Emerson Electric Company (EMR) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
Emerson Electric Company (EMR) is a specialty industrial machinery company listed on NYSE.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported EMR revenue for 2025-09-30 was $4.86B. Net income was $2.25B. Revenue was up 6.6% from 2025-06-30 to 2025-09-30. EMR currently screens at market cap $83.45B and trailing P/E 34.5.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
EMR currently screens at market cap $83.45B and trailing P/E 34.5. VIR currently screens at market cap $1.45B.
Not investment advice. Open the EMR and VIR stock pages for the full models.
Not investment advice.